You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
A pilot study enrolling up to 15 patients will validate CapeDx's utility to match patients to approved drugs and clinical trials based on whole-genome and tumor sequencing.
The grants were awarded as part of Australia's Genomics Health Futures Mission, which was launched in 2018 as part of a broader health research initiative.
The national project has developed infrastructure for implementing genomics into clinical care and is now studying clinical utility and cost effectiveness.
Following the launch of GenoVic last year, the organization is working to get more centers on the platform and figure out its role in an A$500M national initiative.
The Australian government has announced that it is cutting research funding, Nature News says.
Australian insurers propose a cap for insurance policies below which customers don't have to disclose adverse genetic testing results, according to the Australian.
An Australian minister stopped the funding of 11 humanities projects selected through peer review, raising concerns among academics, Nature News reports.
It will be possible to upload genomic data to Australia's My Health Record system, which has raised privacy issues, the Sydney Morning Herald reports.
The Australian Genomics Health Futures Mission will include a series of studies to tackle rare diseases and cancers.
The new Australian federal budget includes funds for genomic research, according to the Australian Financial Review.
The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.
The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.
Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.
In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.